Search

Author/Creator Schubert, Philipp

2. Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent/metastatic cancer to immune checkpoint inhibitors. Issue 2 (16th February 2021)

Authors:
Zhou, Jian-Guo; Donaubauer, Anna-Jasmina; Frey, Benjamin; Becker, Ina; Rutzner, Sandra; Eckstein, Markus; Sun, Roger; Ma, Hu; Schubert, Philipp; Schweizer, Claudia; Fietkau, Rainer; Deutsch, Eric; Gaipl, Udo; Hecht, Markus
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 2(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Prospective evaluation of the prognostic value of immune-related adverse events in patients with non-melanoma solid tumour treated with PD-1/PD-L1 inhibitors alone and in combination with radiotherapy. (November 2020)

Authors:
Schweizer, Claudia; Schubert, Philipp; Rutzner, Sandra; Eckstein, Markus; Haderlein, Marlen; Lettmaier, Sebastian; Semrau, Sabine; Gostian, Antoniu-Oreste; Frey, Benjamin; Gaipl, Udo S.; Zhou, Jian-Guo; Fietkau, Rainer; Hecht, Markus
Journal:
European journal of cancer
Issue:
Volume 140(2020)
Page Start:
55
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗